MYC and plasma cell myeloma: We first examined the expression levels of c-Myc mRNA in five myeloma cell lines following the treatment with one of nine HDACi (Fig. 5B) and the significant reductions in mRNA expression levels of each myeloma cell were validated after 48 hours of exposure to each HDACi.